Abstract
Brigatinib (Alunbrig(R)) is an oral, potent and selective anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) tyrosine kinase inhibitor appro......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
